At a glance
ClinicalIndex Comparison RecordN/ACompleted· 61 enrolled
Drug / intervention
marketed analgesic +3 moredrug
Likely dose
marketed analgesic 200 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Pilot Study To Evaluate Various Methodologies For Assessing The Treatment Of Low Back Pain
Wyeth is now a wholly owned subsidiary of Pfizer·interventional·Posted Jan 11, 2010·Updated Apr 1, 2013
In Brief
A clinical study evaluating Heat Device, Sham Device, and 2 other interventions for Pain. Completed, enrolled 61 participants across 1 site.
Detailed Summary
The study is designed to assess methods used in clinical research.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedJan 2010
Enrollment StartFeb 2010
Primary CompletionJul 2010
TodayJul 2026
First PostedJan 11, 2010
Enrollment StartFeb 1, 2010
Primary CompletionJul 1, 2010
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 16.5 years ago
Interventions
Heat Devicedevice
8-Hour Heatwrap
Sham Devicedevice
Inactive wrap worn for 8 hours
marketed analgesicdrug
2 x 200 mg ibuprofen tablets
Placebodrug
2 x placebo tablets